Rocamed
FranceEntry
2024
Hold
2yr
Status
Active
Who owns Rocamed?
Rocamed is a French MedTech company, currently owned by 21 Invest since 2024 and Stags Participations.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
21 Invest21 Invest France Fund VI · 2022 · Buyout
3 ownership periods · full history below
Key facts
HQFrance
SectorMedTech
Ownership history
2 ownership periods · co-invest detected · 1 lender on file
Active
Co-invest · 2 holders · 1 lender · 2018 · present
Stags ParticipationsActive
2018 · present(8yr) · Stags Participations · 2011 · Growth
Zencap AMLender
2024 · present(2yr) · Zencap Direct Lending IV · 2023 · Private Debt
21 InvestActive
2024 · present(2yr) · 21 Invest France Fund VI · 2022 · Buyout
More from 21 Invest France Fund VI
Other portfolio companies in the same fund.
ItalyMore PE-backed in MedTech
Comparable medtech deals from other GPs.
US
GermanyQuestions
Who owns Rocamed?
Rocamed is currently owned by 21 Invest and Stags Participations, through 21 Invest France Fund VI, since 2024.
When did 21 Invest and 1 other acquire Rocamed?
21 Invest and 1 other acquired Rocamed in 2024.
Who has owned Rocamed over time?
Rocamed has been through 3 private-equity ownership periods: Stags Participations · via Stags Participations · since 2018; 21 Invest · via 21 Invest France Fund VI · since 2024; Zencap AM · via Zencap Direct Lending IV · since 2024.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue